- Home
- VNDA vs NOTE Comparison
VNDA vs NOTE Comparison
Compare VNDA & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- NOTE
- Stock Information
- Founded
- VNDA 2002
- NOTE 2013
- Country
- VNDA United States
- NOTE United States
- Employees
- VNDA N/A
- NOTE N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- NOTE EDP Services
- Sector
- VNDA Health Care
- NOTE Technology
- Exchange
- VNDA Nasdaq
- NOTE Nasdaq
- Market Cap
- VNDA 282.8M
- NOTE 133.5M
- IPO Year
- VNDA 2006
- NOTE N/A
- Fundamental
- Price
- VNDA $4.99
- NOTE $0.99
- Analyst Decision
- VNDA Strong Buy
- NOTE Strong Buy
- Analyst Count
- VNDA 2
- NOTE 6
- Target Price
- VNDA $16.50
- NOTE $2.80
- AVG Volume (30 Days)
- VNDA 673.5K
- NOTE 2.8M
- Earning Date
- VNDA 05-07-2025
- NOTE 03-13-2025
- Dividend Yield
- VNDA N/A
- NOTE N/A
- EPS Growth
- VNDA N/A
- NOTE N/A
- EPS
- VNDA N/A
- NOTE 0.07
- Revenue
- VNDA $198,772,000.00
- NOTE $120,266,000.00
- Revenue This Year
- VNDA $14.36
- NOTE $3.76
- Revenue Next Year
- VNDA $44.53
- NOTE $12.16
- P/E Ratio
- VNDA N/A
- NOTE $14.32
- Revenue Growth
- VNDA 3.18
- NOTE N/A
- 52 Week Low
- VNDA $3.71
- NOTE $0.75
- 52 Week High
- VNDA $6.75
- NOTE $2.07
- Technical
- Relative Strength Index (RSI)
- VNDA 57.32
- NOTE 39.40
- Support Level
- VNDA $4.84
- NOTE $0.80
- Resistance Level
- VNDA $5.16
- NOTE $1.11
- Average True Range (ATR)
- VNDA 0.23
- NOTE 0.11
- MACD
- VNDA 0.02
- NOTE -0.02
- Stochastic Oscillator
- VNDA 66.10
- NOTE 37.83
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.